AVITA MEDICAL, INC. (RCEL) Gross margin 2018–2025
AVITA MEDICAL, INC. (RCEL) gross margin by fiscal year — reported gross profit divided by reported revenue.
82.1%FY2025 · since FY2018: 41.2% → 82.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 82.1% | -3.7 pp |
| FY2024 | 85.8% | +1.4 pp |
| FY2023 | 84.5% | +2.0 pp |
| FY2022 | 82.4% | +2.8 pp |
| FY2021 | 79.6% | +0.5 pp |
| FY2020 | 79.2% | +2.4 pp |
| FY2019 | 76.8% | +35.6 pp |
| FY2018 | 41.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice